170 related articles for article (PubMed ID: 18397366)
1. A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells.
Choi DH; Kim EM; Son HJ; Joh TH; Kim YS; Kim D; Flint Beal M; Hwang O
J Neurochem; 2008 Jul; 106(1):405-15. PubMed ID: 18397366
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-3 contributes to vulnerability of the nigral dopaminergic neurons.
Kim ST; Kim EM; Choi JH; Son HJ; Ji IJ; Joh TH; Chung SJ; Hwang O
Neurochem Int; 2010 Jan; 56(1):161-7. PubMed ID: 19815046
[TBL] [Abstract][Full Text] [Related]
3. Regulation of matrix metalloproteinase-9 gene expression in MPP+- or 6-OHDA-treated human neuroblastoma SK-N-BE(2)C cells.
Kim SY; Woo MS; Park JS; Kim HS
Neurochem Int; 2010 Feb; 56(3):437-42. PubMed ID: 19962414
[TBL] [Abstract][Full Text] [Related]
4. Critical role of ASK1 in the 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells.
Ouyang M; Shen X
J Neurochem; 2006 Apr; 97(1):234-44. PubMed ID: 16515547
[TBL] [Abstract][Full Text] [Related]
5. A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation.
Kim YS; Choi DH; Block ML; Lorenzl S; Yang L; Kim YJ; Sugama S; Cho BP; Hwang O; Browne SE; Kim SY; Hong JS; Beal MF; Joh TH
FASEB J; 2007 Jan; 21(1):179-87. PubMed ID: 17116747
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of nerve growth factor on dopaminergic neurotoxin-induced apoptosis.
Hirata Y; Meguro T; Kiuchi K
J Neurochem; 2006 Oct; 99(2):416-25. PubMed ID: 17029596
[TBL] [Abstract][Full Text] [Related]
7. JNK activation by tetrahydrobiopterin: implication for Parkinson's disease.
Choi HJ; Lee SY; Cho Y; Hwang O
J Neurosci Res; 2004 Mar; 75(5):715-21. PubMed ID: 14991847
[TBL] [Abstract][Full Text] [Related]
8. A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats.
Pain S; Barrier L; Deguil J; Milin S; Piriou A; Fauconneau B; Page G
Toxicology; 2008 Jan; 243(1-2):124-37. PubMed ID: 18037221
[TBL] [Abstract][Full Text] [Related]
9. K252a prevents nigral dopaminergic cell death induced by 6-hydroxydopamine through inhibition of both mixed-lineage kinase 3/c-Jun NH2-terminal kinase 3 (JNK3) and apoptosis-inducing kinase 1/JNK3 signaling pathways.
Pan J; Wang G; Yang HQ; Hong Z; Xiao Q; Ren RJ; Zhou HY; Bai L; Chen SD
Mol Pharmacol; 2007 Dec; 72(6):1607-18. PubMed ID: 17855652
[TBL] [Abstract][Full Text] [Related]
10. HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells.
Wang Y; Wang X; Liu L; Wang X
Neurosci Lett; 2009 Dec; 467(3):212-6. PubMed ID: 19835929
[TBL] [Abstract][Full Text] [Related]
11. Particular vulnerability of rat mesencephalic dopaminergic neurons to tetrahydrobiopterin: Relevance to Parkinson's disease.
Lee SY; Moon Y; Hee Choi D; Jin Choi H; Hwang O
Neurobiol Dis; 2007 Jan; 25(1):112-20. PubMed ID: 17049260
[TBL] [Abstract][Full Text] [Related]
12. MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation--relevance in a mouse model of Parkinson's disease.
Thomas T; Timmer M; Cesnulevicius K; Hitti E; Kotlyarov A; Gaestel M
J Neurochem; 2008 Jun; 105(5):2039-52. PubMed ID: 18298661
[TBL] [Abstract][Full Text] [Related]
13. Involvement of multiple protein kinases in cPLA2 phosphorylation, arachidonic acid release, and cell death in in vivo and in vitro models of 1-methyl-4-phenylpyridinium-induced parkinsonism--the possible key role of PKG.
Chalimoniuk M; Stolecka A; Ziemińska E; Stepień A; Langfort J; Strosznajder JB
J Neurochem; 2009 Jul; 110(1):307-17. PubMed ID: 19457107
[TBL] [Abstract][Full Text] [Related]
14. Medial forebrain bundle axotomy during development induces apoptosis in dopamine neurons of the substantia nigra and activation of caspases in their degenerating axons.
El-Khodor BF; Burke RE
J Comp Neurol; 2002 Oct; 452(1):65-79. PubMed ID: 12205710
[TBL] [Abstract][Full Text] [Related]
15. Suppression of caspase-3-dependent proteolytic activation of protein kinase C delta by small interfering RNA prevents MPP+-induced dopaminergic degeneration.
Yang Y; Kaul S; Zhang D; Anantharam V; Kanthasamy AG
Mol Cell Neurosci; 2004 Mar; 25(3):406-21. PubMed ID: 15033169
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-3 is activated by HtrA2/Omi in dopaminergic cells: relevance to Parkinson's disease.
Shin EJ; Kim EM; Lee JA; Rhim H; Hwang O
Neurochem Int; 2012 Feb; 60(3):249-56. PubMed ID: 22265821
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia.
Woo MS; Park JS; Choi IY; Kim WK; Kim HS
J Neurochem; 2008 Jul; 106(2):770-80. PubMed ID: 18419763
[TBL] [Abstract][Full Text] [Related]
18. Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine.
Rodriguez-Blanco J; Martín V; Herrera F; García-Santos G; Antolín I; Rodriguez C
J Neurochem; 2008 Oct; 107(1):127-40. PubMed ID: 18665912
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of manganese exposure-induced dopaminergic toxicity.
Prabhakaran K; Ghosh D; Chapman GD; Gunasekar PG
Brain Res Bull; 2008 Jul; 76(4):361-7. PubMed ID: 18502311
[TBL] [Abstract][Full Text] [Related]
20. Novel imine antioxidants at low nanomolar concentrations protect dopaminergic cells from oxidative neurotoxicity.
Hajieva P; Mocko JB; Moosmann B; Behl C
J Neurochem; 2009 Jul; 110(1):118-32. PubMed ID: 19486265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
